JYNT

Business Context and Reporting Period

Company: The Joint Corp. (JYNT)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2026
Business Model: Franchisor of chiropractic clinics operating on a private-pay, non-insurance model. The company is executing a strategic shift to refranchise its entire portfolio of company-owned clinics, classifying the corporate clinic segment as discontinued operations as of December 31, 2024.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total revenues from continuing operations increased 13.9% to $30.0 million for the six months ended June 30, 2026, compared to $26.3 million in the prior year period. This was driven by a 58.7% increase in advertising fund revenue and an 18.7% increase in franchise fees.
• Profitability Improvement: Continuing operations turned profitable, reporting net income of $0.85 million compared to a net loss of $1.5 million in the prior year period. Operating income improved from a loss of $1.8 million to income of $0.5 million.
• Expense Trends: Selling and marketing expenses increased 23.1% due to national marketing campaigns. General and administrative expenses remained relatively flat (-0.1%) as payroll reductions from the refranchising strategy offset increases in professional and litigation services.
• Cash Flow: Net cash provided by operating activities improved significantly to $0.7 million from a use of $2.8 million in the prior year, largely due to the timing of a medical injury claim settlement in 2025.

Guidance, Outlook, and Risks

Management Commentary & Strategy: The company is focused on completing the refranchising of its 45 remaining company-owned clinics. Significant transactions include the sale of 45 clinics in Southern California to Elite Chiro Group (partially closed) and 22 clinics in the Carolinas/Virginia (partially closed). Management anticipates 2026 to remain a volatile macroeconomic environment with headwinds from labor shortages and inflation.

Liquidity: Management believes existing cash ($22.2 million), anticipated operating cash flows, and the available $20.0 million revolver (currently unutilized) are sufficient to fund operations for the next 12 months. The credit facility maturity was extended to August 31, 2029.

Risks and Contingencies:

• Litigation: The company is defending multiple lawsuits in California alleging negligence, invasion of privacy, and sexual harassment. While insurance coverage is expected to limit exposure, the outcome is uncertain, and no accrual exists for potential liability beyond insurance deductibles.
• Refranchising Execution: Failure to successfully sell or refranchise the remaining corporate clinics could impact financial results.
• Macroeconomic Factors: Elevated interest rates, inflation, and labor shortages may reduce consumer spending and increase operating costs.

Investor Verification Checklist

• Refranchising Progress: Verify the closing status of the Elite Chiro Group and Carolinas/Virginia clinic sales, as these transactions are critical to the strategic shift and balance sheet cleanup.
• Litigation Exposure: Monitor developments in the California class action and individual lawsuits to assess potential insurance coverage gaps or reputational damage.
• Franchisee Health: Review same-store sales ("Comp Sales") trends, which decreased 2.8% in Q2 2026, to gauge the underlying demand for franchisee services.
• Capital Allocation: Track the remaining $3.8 million authorized for stock repurchases and the company's ability to maintain liquidity while funding marketing initiatives.